Professional role
a member of The Molecular Carcinogenesis and Chemoprevention (MCC) Program at The Ohio State University Comprehensive Cancer Center (OSUCCC)[1]
DX
leads to discoveries of novel non-canonical functions of hTERT protein and a novel cell culture technology
mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways
Reviewed sources document mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways. Explore attributed publications and research affiliations.
Explore researcha member of The Molecular Carcinogenesis and Chemoprevention (MCC) Program at The Ohio State University Comprehensive Cancer Center (OSUCCC)[1]
professor[1]
professor in Departments of Pathology (primary), Urology (secondary), and Radiation Oncology (secondary)[1]
mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
6 source claims · Reviewed Sep 9, 2026
Biographical context: leads to discoveries of novel non-canonical functions of hTERT protein and a novel cell culture technology
Dr. Xuefeng Liu is a professor in Departments of Pathology (primary), Urology (secondary), and Radiation Oncology (secondary), and a member of The Molecular Carcinogenesis and Chemoprevention (MCC) Program at The Ohio State University Comprehensive Cancer Center (OSUCCC). His research focuses on mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways, and leads to discoveries of novel non-canonical functions of hTERT protein and a novel cell culture technology.
Identity: Dr. Xuefeng Liu
Dr. Xuefeng Liu is a professor in Departments of Pathology (primary), Urology (secondary), and Radiation Oncology (secondary), and a member of The Molecular Carcinogenesis and Chemoprevention (MCC) Program at The Ohio State University Comprehensive Cancer Center (OSUCCC). His research focuses on mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways, and leads to discoveries of novel non-canonical functions of hTERT protein and a novel cell culture technology.
Professional role: a member of The Molecular Carcinogenesis and Chemoprevention (MCC) Program at The Ohio State University Comprehensive Cancer Center (OSUCCC)
Dr. Xuefeng Liu is a professor in Departments of Pathology (primary), Urology (secondary), and Radiation Oncology (secondary), and a member of The Molecular Carcinogenesis and Chemoprevention (MCC) Program at The Ohio State University Comprehensive Cancer Center (OSUCCC). His research focuses on mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways, and leads to discoveries of novel non-canonical functions of hTERT protein and a novel cell culture technology.
Professional role: professor
Dr. Xuefeng Liu is a professor in Departments of Pathology (primary), Urology (secondary), and Radiation Oncology (secondary), and a member of The Molecular Carcinogenesis and Chemoprevention (MCC) Program at The Ohio State University Comprehensive Cancer Center (OSUCCC). His research focuses on mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways, and leads to discoveries of novel non-canonical functions of hTERT protein and a novel cell culture technology.
Professional role: professor in Departments of Pathology (primary), Urology (secondary), and Radiation Oncology (secondary)
Dr. Xuefeng Liu is a professor in Departments of Pathology (primary), Urology (secondary), and Radiation Oncology (secondary)
Research interests: mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways
His research focuses on mechanisms of bypassing cell senescence with oncogenic-viruses or cellular telomerase related pathways